- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Spanish HealthCare.gov Lags in Sign-ups
What we're reading, November 30, 2015: the Spanish language HealthCare.gov is lagging in sign-ups; the overall federal insurance exchange has fewer preferred provider organizations; and many Americans don't understand why they need the flu vaccine.
Federal Insurance Exchange Struggles to Attract Spanish-Speaking Individuals
The Spanish version of HealthCare.gov is signing up fewer people than last year, according to federal figures. During the first 3 weeks of open enrollment, only 153,000 people used cuidadodesalud.gov compared with 244,000 during the same period last year, according to Washington Post. Overall, the federal insurance exchange is having a more difficult time attracting newcomers.
Many Americans Don’t Understand Why They Need the Flu Vaccine
Less than two-thirds of people say they have been vaccinated or intend to get vaccinated against the flu. Of those who have not been immunized and don’t plan to, more than half don’t see the reason either because they believe the flu shot is unnecessary for them (48%) or because they think the vaccination is ineffective (8%). NPR reported age, not income or education, was the biggest differentiator of whether or not people would get vaccinated.
On HealthCare.gov, There Are Fewer PPOs and They Are Increasingly Expensive
Preferred provider organizations (PPOs) that pay for a portion of the costs for out-of-network hospitals and physicians are becoming less common on the health insurance marketplaces. In addition, Kaiser Health News found that premiums for PPOs are rising faster than more restrictive networks, like health maintenance organizations.
Elevated Inflammatory Marker Levels Associated With Increased Overactive Bladder Risk
April 15th 2025Systemic immune inflammation index, neutrophil-to-lymphocyte ratio, and systemic inflammation response index levels may offer a noninvasive method to identify individuals at increased risk of developing overactive bladder.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Significant Disease Burden and Management Issues in Chronic Spontaneous Urticaria
April 15th 2025Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for better management and understanding of the condition.
Read More
Lifestyle Interventions, Statins, Among Keys to Mitigating CVD Risk in MASLD/MASH
April 15th 2025A recent review highlights the gaps in clinical guidelines and treatment approaches for metabolic dysfunction-associated steatohepatitis (MASH) and looks ahead to the future promise of glucagon-like peptide 1 (GLP-1) receptor agonists for liver conditions.
Read More
